Government of Indonesia
Also known as: Center for R & D of Health Resources and Services, National Institute of Health Research and Development (NIHRD), Indonesia | Center for Research and Development of Health Resources and Services, National Institute of Health Research and Development (NIHRD), Indonesia | Hasan Sadikin General Hospital | Health Development Policy Agency, Ministry of Health Republic of Indonesia | Indonesia Ministry of Health | Indonesia-MoH | Ministry of Agriculture, Republic of Indonesia | Ministry of Education, Culture, Research, and Technology, Republic of Indonesia | Ministry of Health, Indonesia | Ministry of Research, Technology and Higher Education, Republic of Indonesia | National Institute of Health Research and Development | National Institute of Health Research and Development, Ministry of Health Republic of Indonesia | National Intitute of Health Research and Development, Ministry of Health Republic of Indonesia | National Research and Innovation Agency of Indonesia | Provincial Government of Central Java, Indonesia | Research Center for Chemistry, National Research and Innovation Agency of Indonesia | The Indonesia Endowment Funds for Education, Ministry of Finance Indonesia
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2011Last known activity
Jul 1, 2025
Timeline
1940s
- Aug 17, 1945
Government of Indonesia— Founded
Drugs by trial phase (32 distinct, 27 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (19 own, 0 via acquisition)
- diphtheria-tetanus-whole cell pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine
- ginger
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- artesunate
- mangosteen
- hepatitis b vaccine (recombinant)
- primaquine
- solanum melongena peel extract
- azithromycin
- amodiaquine
- turmeric
- mrna-1273
- favipiravir
- COVID-19 convalescent plasma
- inactivated SARS-Cov-2 vaccine
- +4 more
Phase 2 (5 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (38)
- NCT07016113OfficialPhase 2Jul 1, 2025
- NCT07183215Sponsor investigatorPhase 2/Phase 3Jun 1, 2025
- NCT06259578CollaboratorEarly Phase 1Jan 29, 2024
- NCT06272253CollaboratorEarly Phase 1Sep 19, 2023
- NCT06066827CollaboratorN/AAug 14, 2023
- NCT06282692CollaboratorPhase 3Jun 19, 2023
- NCT05387317CollaboratorPhase 3Feb 28, 2023
- NCT05482282Overall official - principal investigatorPhase 3Oct 31, 2022
- NCT05482282CollaboratorPhase 3Oct 31, 2022
- NCT05918939CollaboratorEarly Phase 1Sep 5, 2022
- NCT05508477CollaboratorPhase 3Jun 28, 2022
- NCT05277155CollaboratorPhase 2/Phase 3Feb 22, 2022
- NCT05277155Lead sponsorPhase 2/Phase 3Feb 22, 2022
- NCT05277155Study directorPhase 2/Phase 3Feb 22, 2022
- NCT05277155OfficialPhase 2/Phase 3Feb 22, 2022
Details
- Founded
- Jakarta, ID Aug 17, 1945
- Last known activity
- Jul 1, 2025